Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2019

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
This is a long-term, open-label, multicenter, study to evaluate the safety and efficacy of topical tapinarof cream, 1% in adults with plaque psoriasis. Subjects in this study completed treatment in 1 of 2 Phase 3 pivotal efficacy and safety studies (Study DMVT-505-3001 or Study DMVT-505-3002). This study will consist of up to 40 weeks of treatment and a 4-week safety follow-up period.
Epistemonikos ID: c28c9c0545418ee4de492be9668d7e1c67fc67d7
First added on: May 22, 2024